Building the NHS Business Case: Creating the Case for Change Before Adoption 

Most pharma, medtech and device companies accept that, sooner or later, a business case will be required to unlock meaningful NHS adoption. Teams expect to be asked for clinical evidence, cost-effectiveness data, outcomes modelling and impact projections. Many are well rehearsed in responding to those requests and invest heavily in data generation and slide decks designed to support them. 

And yet, despite strong evidence and positive early conversations, business cases still stall, get parked or quietly disappear. Projects that felt promising lose momentum. Pilots fail to scale. Internal NHS champions go silent. 

The reason is rarely the quality of the product or the robustness of the data. 

More often, it is because the business case has been built before the case for change was ever properly established. 

This is one of the most common, and costly, mistakes industry makes when engaging with the NHS. 

In this article, I explain why NHS business cases fail, how to create a genuine case for change, and what industry teams must do differently to achieve real adoption, drawing on principles explored in my book Embedded. 

Creating the Case for Change in the NHS (Why Business Cases Stall Without It) 

Industry teams tend to move quickly to solutions. A medicine, device or service clearly improves outcomes, reduces variation or saves money. From an external perspective, the need for change feels obvious. 

Inside the NHS, it often isn’t. 

The NHS is not short of good ideas. It is short of capacity, headspace and tolerance for risk. Every system is managing multiple competing priorities under intense operational and financial pressure. Even well-evidenced innovations must compete with workforce shortages, performance targets, regulatory scrutiny and political pressure. 

Before NHS leaders ask, “How would this work?”, they are asking something far more fundamental, why does this need to change at all, and why now? 

If that question has not been answered clearly, locally and credibly, no business case will ever gain traction. 

Creating the case for change is not about citing national policy or generic statistics. It is about helping NHS teams articulate, in their own words, why the current state is no longer acceptable, sustainable or safe. That usually means surfacing uncomfortable truths about demand, capacity, variation, outcomes or workforce strain. 

Until that happens, any business case remains theoretical. 

Why Good NHS Innovation Proposals Still Fail to Scale 

From an industry perspective, it can be baffling. You may see unwarranted variation, late diagnosis, suboptimal treatment or inefficiency that appears self-evident. But NHS teams live with these issues every day. What looks broken from the outside may feel normalised, tolerated or unavoidable inside the system. 

This is why so many proposals are met with polite interest but little urgency. 

A genuine case for change usually emerges when one or more pressures converge: 

• Demand is rising faster than capacity   

• Workforce strain is creating safety or sustainability risk   

• Outcomes are increasingly scrutinised   

• Financial pressure is becoming untenable   

• Variation is no longer defensible   

• Contractual or regulatory expectations are being missed   

Your role as an industry partner is not to tell the NHS that change is needed. It is to help them recognise, articulate and evidence that need themselves, using their own data and experience. 

From Case for Change to NHS Business Case: What Changes 

Once the case for change is shared and owned, the business case becomes far easier to build. At that point, the conversation shifts from whether something should happen to how it can be delivered safely, affordably and at scale. 

This is where many industry teams misunderstand the purpose of an NHS business case. 

It is not simply a funding request. It is an internal document NHS leaders use to: 

• Align clinical, operational and financial stakeholders   

• Reduce perceived delivery risk   

• Justify decisions to boards, regulators and auditors   

• Protect themselves and their organisations if things go wrong   

Seen through this lens, it becomes clear why business cases fail when they are written for the NHS rather than with it. 

Why co-authoring matters  

The strongest business cases are co-authored. NHS partners own the narrative, language and framing. Industry supports with structure, evidence, delivery insight and examples from elsewhere. 

This matters because NHS leaders are not just approving a proposal. They are attaching their credibility to it. 

Co-authored business cases: 

• Reflect local priorities and language   

• Anticipate internal objections   

• Demonstrate shared ownership   

• Feel safer to support   

Externally written cases, however polished, often feel optimistic or disconnected from operational reality. 

Your job is not to impress the NHS. It is to help NHS leaders make a confident internal decision. 

What the business case needs to answer 

While formats vary, most NHS business cases must answer the same core questions. 

What is the problem, and why now? 

This is where the case for change must be explicit. What risks does inaction carry? Why can’t this wait another year? Local data beats national averages every time. 

What will change in practice? 

Clarity matters. Who does what differently tomorrow? What stops happening? What improves? Ambiguity creates risk. 

Who delivers it? 

Assuming clinicians will absorb more work is the fastest way to lose support. Successful cases are explicit about workforce models, roles and capacity protection. 

How is it funded? 

Even strong ideas stall if funding routes are unclear. Mapping to existing mechanisms such as PCN DES, ARRS, Enhanced Access or ICS transformation funding reduces friction. 

What outcomes will improve? 

Outcomes must matter to the system, including, reduced appointments, avoided admissions, improved long term condition control, reduced variation, released workforce time. 

Addressing risk openly 

NHS leaders are professionally accountable for risk. Strong business cases address it explicitly, covering information governance, digital integration, clinical safety, workforce sustainability and exit planning. 

This does not weaken a proposal. It builds trust. 

Why this approach changes everything  

When industry helps create the case for change and co-authors the business case, proposals stop being “industry projects”. They become NHS solutions. 

At that point, internal advocacy replaces external selling. Momentum builds. Scale becomes possible. 

The NHS does not commission products. It commissions confidence. 

Confidence that change is needed. 

Confidence it can be delivered. 
 

Confidence that risk has been thought through. 

What This Means in Practice 

For pharmaceutical, medtech and device companies, this requires a subtle but important shift in mindset. 

NHS adoption does not begin with a product, a pilot or a business case. It begins with a shared understanding that the current state is no longer good enough, and that doing nothing now carries greater risk than doing something different. 

When industry skips that step, even the strongest proposals struggle. When it gets it right, progress accelerates. Conversations become more honest. Internal NHS advocacy replaces external persuasion. Business cases stop feeling like hurdles and start functioning as enablers. 

This is why success in the NHS is less about having the right answers and more about asking the right questions; early, locally and with the people who carry delivery risk. 

Once the case for change is genuinely owned by the system, the business case becomes a practical exercise rather than a political one. And that is when adoption moves from possibility to probability. 

About the book 

These principles are explored in more depth in my book Embedded: How Pharma, MedTech, and Device Companies Can Get Their Innovations into NHS Pathways – and Keep Them There is written for teams navigating exactly this challenge: moving from good conversations to real NHS adoption. The book distils over 20 years of frontline NHS and industry experience into a practical guide for teams who want to move beyond good conversations and achieve real, sustained results. 

Importantly, purchasers of the book also receive an exclusive practical resource: my Creating the Case for Change template. This is the exact framework I use in NHS work to help industry and NHS partners surface the real problem, build shared urgency and lay the foundations for business cases that actually move. 

Because the difference between approval and adoption is rarely the product. 

It is the groundwork that comes before the business case is ever written.